Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.52
0.06 (4.11%)
At close: Jun 30, 2025, 3:59 PM
1.53
0.66%
After-hours: Jun 30, 2025, 05:06 PM EDT
4.11%
Bid 1.4
Market Cap 17.2M
Revenue (ttm) 5.7M
Net Income (ttm) -12.78M
EPS (ttm) -1.32
PE Ratio (ttm) -1.15
Forward PE -0.83
Analyst Strong Buy
Ask 1.53
Volume 51,300
Avg. Volume (20D) 105,388
Open 1.51
Previous Close 1.46
Day's Range 1.49 - 1.55
52-Week Range 0.95 - 5.99
Beta 1.45

About MRKR

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
+33.33%
Marker Therapeutics shares are trading higher afte... Unlock content with Pro Subscription
6 months ago
-7.44%
Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.
No News article available yet